FibroBiologics Statistics

Total Valuation

FibroBiologics has a market cap or net worth of $33.38 million. The enterprise value is $31.83 million.

Market Cap	33.38M
Enterprise Value	31.83M

Important Dates

The next estimated earnings date is Wednesday, August 6, 2025, after market close.

Earnings Date	Aug 6, 2025
Ex-Dividend Date	n/a

Share Statistics

FibroBiologics has 38.26 million shares outstanding. The number of shares has increased by 18.32% in one year.

Current Share Class	38.26M
Shares Outstanding	38.26M
Shares Change (YoY)	+18.32%
Shares Change (QoQ)	+7.46%
Owned by Insiders (%)	20.09%
Owned by Institutions (%)	16.97%
Float	28.44M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	14.01
P/TBV Ratio	14.21
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.14, with a Debt / Equity ratio of 3.03.

Current Ratio	1.14
Quick Ratio	1.06
Debt / Equity	3.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-926.13

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-81.15%
Return on Invested Capital (ROIC)	-240.21%
Return on Capital Employed (ROCE)	-460.90%
Revenue Per Employee	n/a
Profits Per Employee	-$589,769
Employee Count	13
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -88.86% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-88.86%
50-Day Moving Average	0.94
200-Day Moving Average	1.86
Relative Strength Index (RSI)	48.17
Average Volume (20 Days)	279,534

Short Selling Information

The latest short interest is 1.25 million, so 3.27% of the outstanding shares have been sold short.

Short Interest	1.25M
Short Previous Month	1.57M
Short % of Shares Out	3.27%
Short % of Float	4.39%
Short Ratio (days to cover)	6.63

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-14.82M
Pretax Income	-19.47M
Net Income	-7.67M
EBITDA	-14.64M
EBIT	-14.82M
Earnings Per Share (EPS)	-$0.22

Full Income Statement

Balance Sheet

The company has $8.67 million in cash and $7.12 million in debt, giving a net cash position of $1.55 million or $0.04 per share.

Cash & Cash Equivalents	8.67M
Total Debt	7.12M
Net Cash	1.55M
Net Cash Per Share	$0.04
Equity (Book Value)	2.35M
Book Value Per Share	0.06
Working Capital	1.12M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$12.90 million and capital expenditures -$219,000, giving a free cash flow of -$13.12 million.

Operating Cash Flow	-12.90M
Capital Expenditures	-219,000
Free Cash Flow	-13.12M
FCF Per Share	-$0.34

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FibroBiologics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.32%
Shareholder Yield	-18.32%
Earnings Yield	-22.97%
FCF Yield	-39.30%

Analyst Forecast

The average price target for FibroBiologics is $13.00, which is 1,389.97% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.00
Price Target Difference	1,389.97%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	13.06%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1